Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report

Half-year ReportInterim Results for the period ended 30 June 2026LONDON, UK / / September 28, 2026 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the"Company") LSE:HEMO, the biopharmaceutical group developing therapies designed to transform blood disease treatment…